Page 3 - Derekj Maetzold News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Derekj maetzold. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Derekj Maetzold Today - Breaking & Trending Today

Castle Biosciences, Inc. (NASDAQ:CSTL) Short Interest Up 17.4% in March

Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 1,420,000 shares, an increase of 17.4% from the February 29th total of 1,210,000 shares. Based on an average trading volume of 252,100 shares, […] ....

Castle Biosciences , Derekj Maetzold , Vanguard Group Inc , Wasatch Advisors Inc , Blackrock Inc , Castle Biosciences Inc , Principal Financial Group Inc , Bellevue Group , Securities Exchange Commission , Get Free Report , Biosciences Trading Down , Exchange Commission , Financial Group , Mypath Melanoma , Castle Biosciences Daily ,

Castle Biosciences, Inc. (NASDAQ:CSTL) Insider Derek J. Maetzold Sells 2,295 Shares of Stock

Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) insider Derek J. Maetzold sold 2,295 shares of the firm’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $20.27, for a total transaction of $46,519.65. Following the transaction, the insider now owns 69,806 shares of the company’s stock, […] ....

Derekj Maetzold , Castle Biosciences , Schonfeld Strategic Advisors , Capital Partners , Walleye Capital , Millrace Asset Group Inc , Deerfield Management Companylp Series , Castle Biosciences Company Profile , Securities Exchange Commission , Castle Biosciences Inc , Get Free Report , Exchange Commission , Strategic Advisors , Millrace Asset Group , Mypath Melanoma , Castle Biosciences Daily ,

Deerfield Management Company L.P. Series C Acquires Shares of 946,620 Castle Biosciences, Inc. (NASDAQ:CSTL)

Deerfield Management Company L.P. Series C bought a new position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 946,620 shares of the company’s stock, valued at approximately $15,988,000. Deerfield Management Company L.P. Series […] ....

Daniel Bradbury , Castle Biosciences , Derekj Maetzold , Deerfield Management Companylp Series , Lazard Asset Management , Royal Bank , Securities Exchange Commission , Tower Research Capital , Bluepath Capital Management , Osaic Holdings Inc , Castle Biosciences Company Profile , Castle Biosciences Inc , Free Report , Path Capital Management , Research Capital , Director Daniel Bradbury , Exchange Commission , Biosciences Stock Down , Castle Biosciences Daily ,

Deerfield Management Company L.P. Series C Acquires Shares of 946,620 Castle Biosciences, Inc. (NASDAQ:CSTL)

Deerfield Management Company L.P. Series C Acquires Shares of 946,620 Castle Biosciences, Inc. (NASDAQ:CSTL)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Daniel Bradbury , Castle Biosciences , Derekj Maetzold , Deerfield Management Companylp Series , Royal Bank , Lazard Asset Management , Securities Exchange Commission , Tower Research Capital , Bluepath Capital Management , Osaic Holdings Inc , Castle Biosciences Company Profile , Castle Biosciences Inc , Free Report , Path Capital Management , Research Capital , Director Daniel Bradbury , Exchange Commission , Biosciences Stock Down , Castle Biosciences Daily ,

Castle Biosciences, Inc. (NASDAQ:CSTL) Short Interest Up 29.3% in January

Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) was the target of a large growth in short interest during the month of January. As of January 31st, there was short interest totalling 1,240,000 shares, a growth of 29.3% from the January 15th total of 958,800 shares. Currently, 5.0% of the company’s shares are short sold. […] ....

Derekj Maetzold , Castle Biosciences , Daniel Bradbury , Deerfield Management Companylp Series , Bellevue Group , Citadel Advisors , Granahan Investment Management , Castle Biosciences Company Profile , Millennium Management , Securities Exchange Commission , Castle Biosciences Inc , Get Free Report , Director Daniel Bradbury , Exchange Commission , Investment Management , Castle Biosciences Daily , Nasdaq Cstl ,